A platform for the discovery of new macrolide antibiotics.
about
Macrolide Resistance in Streptococcus pneumoniaeParameter identifiability-based optimal observation remedy for biological networks.Ring-Expansion Approach to Medium-Sized Lactams and Analysis of Their Medicinal Lead-Like Properties.Novel, male-produced aggregation pheromone of the cerambycid beetle Rosalia alpina, a priority species of European conservation concern.Total syntheses of the archazolids: an emerging class of novel anticancer drugs.Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products.Functional Metagenomics as a Tool for Identification of New Antibiotic Resistance Genes from Natural Environments.Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.Nature nurtures the design of new semi-synthetic macrolide antibiotics.Ring-Expansion Reactions in the Synthesis of Macrocycles and Medium-Sized Rings.Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.Applications of Nonenzymatic Catalysts to the Alteration of Natural Products.The macrolide antibiotic renaissance.Natural product analogues: towards a blueprint for analogue-focused synthesis.Convection shapes the trade-off between antibiotic efficacy and the selection for resistance in spatial gradients.Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.Tetrazine Marks the SpotSynthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides.Drug discovery: Fighting evolution with chemical synthesis.Synthesis of Cyclic Peptide Mimetics by the Successive Ring Expansion of Lactams.Are highly morphed peptide frameworks lurking silently in microbial genomes valuable as next generation antibiotic scaffolds?Scalable Access to Arylomycins via C-H Functionalization Logic.Leptolyngbyolides, Cytotoxic Macrolides from the Marine Cyanobacterium Leptolyngbya sp.: Isolation, Biological Activity, and Catalytic Asymmetric Total Synthesis.Natural Products as Platforms To Overcome Antibiotic Resistance.The evolution of substrate discrimination in macrolide antibiotic resistance enzymes.Synthesis and Antibacterial Evaluation of a Series of 11,12-Cyclic Carbonate Azithromycin-3-O-descladinosyl-3-O-carbamoyl Glycosyl Derivatives.Large-scale preparation of key building blocks for the manufacture of fully synthetic macrolide antibiotics.Look and Outlook on Enzyme-Mediated Macrolide ResistanceRibosomal stalling landscapes revealed by high-throughput inverse toeprinting of mRNA librariesHundreds of antibiotics built from scratch
P2860
Q28070243-2ADF9F63-F25F-42DC-9128-88102F32E445Q29994791-3BCC9426-891F-44B6-9B58-EED14B5FE62BQ30490492-C1F2F4B8-4FBD-4BC3-83D7-0B2241291BF4Q38615193-0C5C2653-93B3-4AEA-8302-47E6122D1C5CQ38661592-45E76008-F650-47CB-8692-7ED624B98901Q38745582-F33CCC5B-EF60-4793-B209-4FE1E656978CQ38973296-D925A232-A316-42FC-B87A-7BE58C5EC422Q38980013-63A7E9E9-82F2-4B3D-8F02-AFBB6B343C5BQ39023947-A26D7D72-5B00-47F5-9021-7B45A74EEB1DQ39179647-6E54C06C-D466-4D1A-9B73-360507A0E281Q39258608-695B6994-A041-42EA-89CD-878D13DDCB0BQ39350547-601A63FA-E49E-4B67-9932-D962BD5DE5DFQ39406507-97C8F287-DD63-4A89-ABF7-527D677FC4CCQ39413228-00ACAAD8-2571-42F7-A809-A9F705E27E6CQ40145734-13A5320F-50F6-4CB4-9BAF-FDD1A24542C2Q40176652-7935D655-4706-48E7-8BAF-37F2D3294032Q42331665-2C9B2067-2741-4EC4-8EF8-EA45CEDDFC1AQ46095613-07211166-E4EB-4404-9F0F-857FAE4C03CFQ46929970-04ABD967-ADCA-41B0-905A-31CDC6621DA6Q48103688-24BFB9BD-061F-44E2-A751-FB4D7AB456B3Q48132456-176A8878-1404-4089-BA53-D5DAB0470E82Q48142209-3F826A0B-1700-4653-A5CC-EAA4A0ED90FAQ48259430-4B507000-B55D-4E00-BE05-AA39B3DD9011Q48281604-7484D5EC-7312-462E-8389-20F3331EE2ECQ49306295-ABFE5930-0A51-4BB6-97D2-60057531C396Q50063582-C27B2459-3ADA-4B67-942C-A5532DF5CCF8Q50091487-A40FF37E-A40F-4E13-A2E3-F91E6A52A25BQ58735304-B2E834DF-4B61-4DC9-ACE2-395827832D49Q59136646-B4E30431-81E7-4F21-955C-E0459C465C82Q74437281-D7C1F4EB-0A10-46BC-A0C9-B3949716AF9D
P2860
A platform for the discovery of new macrolide antibiotics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A platform for the discovery of new macrolide antibiotics.
@ast
A platform for the discovery of new macrolide antibiotics.
@en
type
label
A platform for the discovery of new macrolide antibiotics.
@ast
A platform for the discovery of new macrolide antibiotics.
@en
prefLabel
A platform for the discovery of new macrolide antibiotics.
@ast
A platform for the discovery of new macrolide antibiotics.
@en
P2093
P2860
P50
P356
P1433
P1476
A platform for the discovery of new macrolide antibiotics
@en
P2093
Andrew G Myers
Audrey Langlois-Mercier
Daniel T Hog
Ian B Seiple
Peter M Wright
Peter N Carlsen
Senkara Rao Allu
Takehiro Fukuzaki
William D Green
Xiang Zhou
P2860
P2888
P304
P356
10.1038/NATURE17967
P407
P577
2016-05-01T00:00:00Z
P6179
1047068189